Free CME

About 16 text-based or case-based-interactive activities concerned with aspects of HIV infection and AIDS.

All of these categories offer CME credit:
Conference Coverage, Journal Options, Management Series, Treatment Updates, Annual Updates and Interactive Cases.

Topics include:
• Practical Strategies to Engage HIV Patients in Timely Care
• HIV Highlights
• Highlights of Atlanta 2013: ART as Treatment and Prevention
• Highlights of Atlanta 2013: Coinfections and Comorbidities
• Understanding and Addressing Cultural and Socioeconomic Barriers to Effective HIV Management
• Highlights of Glasgow 2012: CCO Independent Conference Coverage of the 2012 International Congress on Drug Therapy in HIV Infection

Target Audience: Physicians focusing on Infectous Disease

About 40 text-based or case-based-interactive activities concerned with aspects of cancer.

All of these categories offer CME credit: Conference Coverage, Journal Options, Management Series, Treatment Updates, Annual Updates and Interactive Cases.

Not all activities offer CME; look for the term, “CME-certified”.

Target Audience: Oncologists

The site includes conferences by experts in endocrinology concerning type 2 diabetes.

You will find presentations on Prediabetes; Metabolic Syndrome; Diabetes and Cardiovascular Disease; Insulin Resistance; Endocrinology; Genetics; Pathophysiology; Treatment therapies; Life Style and Behavior; Epidemiology; Prevention; Childhood Type 2 Diabetes; Guidelines; and Various Others.

Some of the most popular presentations include:
• Metabolic Syndrome and Insulin Resistance
• Pre-Diabetes: Definition
• Obesity and Insulin Resistance: Precursors for Type 2 Diabetes
• Metabolic Syndrome – Does the Diagnosis Make a Difference?
• Measuring Insulin in Clinical Practice

Target Audience: Primary Care Physicians and those focusing on Diabetes.

Activity Description / Statement of Need:

In this online, self-learning activity:

Crohn’s disease (CD) is an inflammatory bowel disease (IBD) that is defined by a transmural process that often occurs in the terminal ileum but may occur in any portion of the GI tract. Although the exact etiology of CD is unknown, a handful of genetic, immunological, and environmental risk factors have been identified, including an impaired immune response to commensal or pathogenic intestinal microbiota that drives mucosal inflammation in patients who are genetically susceptible.

Intestinal and abdominal complications such as strictures, abscesses, and fistulas are common among pediatric patients and increase as the disease progresses. Vitamin and mineral deficiencies have also been attributed to IBD due to mucosal inflammation in the gut, low oral intake, and malnutrition resulting in complications such as poor bone health, delayed puberty, anemia, and stunted growth. The annual direct healthcare costs – accounting for the majority of costs in the U.S. – are about $18,000 to $19,000 per patient. CD shares a number of clinical characteristics with other disease states, and initial misdiagnosis and delayed diagnosis of pCD are not uncommon, which may have a dramatic impact on a patient’s clinical course because pCD is often more severe and associated with a higher incidence of complications than adult CD.

This learning activity has been designed to bring healthcare professionals’ knowledge of the strategies to manage pCD up to date and to improve their competence and performance in treating it.

Target Audience:

The following healthcare professionals: pediatricians, pediatric gastroenterologists, and those who specialize in adolescent medicine; physician assistants, nurse practitioners, and pharmacists; and any other healthcare professionals with an interest in or who clinically encounter patients with pCD.

You will find expert presentations on:
Antiretroviral Therapy; New Agents and Therapeutic Drug Monitoring; Salvage Therapy; Treatment Related Complications; HIV Related Complications; Immunotherapy and Vaccinations; Epidemiology; Basic Science; Social Science; and Others.

Featured Presentations:
• Antiretroviral Therapy in Naive Patient
• HIV/HCV Co-infection
• Management of ART-Experienced and Salvage Patients

Target Audience: Primary Care Physicians

CME Zone offers various courses in many specialties offering CME Credits. The courses are quick and easy to complete.

Target Audiences: General Surgeons, Oncologists, Various Specialties

CME is available in many groups including:
• Disclosure and Apology Series
• Patient Safety Series
• Improving Communications in Health Care
• Key Risk Areas
• Managing a Medical Malpractice Case

Target Audience: Physicians specializing in Risk Management

About 50 activities on various aspects of diabetes. Not all activities offer Physician CME, so be sure to check the type of CME offered before you start. The actual content is located at PRESENTdiabetes.com, but this site (Diabetes in Control) is easier to navigate.

Target Audience: Diabetes professionals

Not all courses offer CME credit for physicians. Some courses offering CME credit include:
• Clinical Dialogues in Pain – OIC
• Opioid Diversion: How, Where, and What Can We Do About It?
• Effective Assessment of Breakthrough Pain

Target Audiences: Physicians specializing in Pain Medicine.

Eleven activities covering various endocrine topics; the most recent are:
• Above and Beyond Glycemic Control
• Above and Beyond Glycemic Control: Reducing the Risk of Cardiovascular Disease
Before the Breaking Point: Reducing the Risk of Osteoporotic Fracture
• Practical Lipidology: Best of Lipid Forum
• Managing the Full Spectrum of Cardiovascular Risk Factors: A Closer Look at GLP-1 Agonists
• The New Treatment Paradigm in Obesity: Proper Patient Selection, Assessment of Comorbidities, and Stepped Interventions
• Dialogues in Diabetes: Volume 2, Number 1
• Growth Hormone Deficiency and Other Causes of Short Stature: Trends in Diagnosis, Evaluation, and Treatment in Children and Adults
• GLP-1 Agonists: Examining New Data on Cardiovascular Risk Reduction, Combination Insulin Therapy, and Adherence
• Weighing in on the Beneficial Effects of GLP-1 Agonists: Assessing Cardiovascular Risk Reduction, Combination Therapy and Adherence
• Cardiovascular Risk Reduction

Target Audience: Physicians specializing in Endocrinology